Xylem Inc
XYL: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|J? | LOCK|l>&! | LOCK|T>?>@$ |
Xylem Earnings: 2025 Outlook Raised as All Four Segments Deliver Strong Revenue Growth
Xylem's second-quarter adjusted EPS of $1.26 easily beat the FactSet consensus estimate by $0.11. Management raised its 2025 guidance and now anticipates full-year adjusted EPS of $4.70-$4.85, up from $4.50-$4.70 previously.
